Connecticut's Department of Consumer Protection today announced combined sales for adult-use cannabis and medical marijuana totaling more than $21 million for April 2023.
The adult-use market recorded $10.2 million in sales during the month of April, while the medical market reached $11.4 million in sales for the same period. Adult-use sales began on January 10, 2023.
In April, Medical Marijuana Patients purchased 314,985 products, and adult-use consumers purchased 259,499.
The average product price for medical patients was $36.51 in April, while the average price of adult-use products was $39.58.
The data was pulled from the state’s seed-to-sale tracking system. The DCP doesn't make revenue projections, set sales expectations, collect taxes or regulate prices.
The preliminary data does not include taxes collected at the point of sale on adult-use transactions and is subject to further review by the department. Medical patients don't pay taxes on the purchase of medicine.
Sales data for the medical marijuana market is not available prior to January 10, 2023 as seed-to-sale tracking was not previously required. All sales are now recorded in BioTrack, the state's inventory tracking system.
Transaction limits of 1/4 ounce of raw flower or the equivalent remain in effect for all adult-use purchases. Medical patients can purchase up to five ounces per month and are not subject to individual transaction limits.
Connecticut approved adult-use in June 2021.
